New analyses show Johnson & Johnson’s one-dose vaccine works well.


F.D.A. studies show the shot strongly protects against severe illness and may reduce spread of the virus. But the drugmaker has fallen short of initial production goals. By Carl Zimmer, Noah Weiland and Sharon LaFraniere from NYT Science https://ift.tt/381g5zx

Leave a Reply